Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes

By S. Connolly, C. Kerr, M. Gent, R. Roberts, S. Yusuf, A. Gillis, M. Sami, M. Talajic, A. Tang, G. Klein and 2 more. 2000

744 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/50f54390010caede78de1c9296d84f964f591803

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

Citations in the corpus

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016, neutral): “In selected patients with sick sinus syndrome and fast ventricular response during AF paroxysms requiring rate control therapy, the addition of a pacemaker not only optimizes rate control but may also help to control rhythm.(711,712) Moreover, when antiarrhythmic drug treatment leads to sinus node d”
2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). (2013, background): “dual-chamber pacing over ventricular pacing with regard to hard clinical endpoints of mortality and morbidity.(2,11,13,14) The benefit of dual-chamber over ventricular pacing is mostly due to the avoidance of PM syndrome, which occurs in more than a quarterof patients with AV block, and to an improv”
Evolution of Wearable Devices with Real-Time Disease Monitoring for Personalized Healthcare (2019, background): “Since cardiac pacemakers were first developed in the 1960s, the number of patients treated with cardiovascular implantable electronic devices, including pacemakers, implantable cardiovascular defibrillators (ICDs) and implantable deep brain stimulators, has been increasing [92,95].”
Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. (2002, neutral): “87 Other cardiac surgery 88 (9) 83 (8) 0.”
Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction (2003, methodology): “For each patient, cumulative percent ventricular paced (Cum%VP) from random assignment to each day of follow-up was calculated by (1) finding, for each visit, the mean percent ventricular paced over all visits up to and including that visit, weighted by the number of days between visits, and (2) usi”
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. (2008, methodology): “CTOPP, which included patients who eceived implants for both SND and AV block, failed to etect any difference between pacing modes with respect to OL or functional status in a subset of 269 patients who nderwent this evaluation; a breakdown by pacing indicaion was not reported (284).”